Anti‐VEGF antibody delivered locally reduces bony bar formation following physeal injury in rats

2020 ◽  
Author(s):  
Christopher B. Erickson ◽  
Jake P. Newsom ◽  
Nathan A. Fletcher ◽  
Yangyi Yu ◽  
Francisco Rodriguez‐Fontan ◽  
...  
Keyword(s):  
Physeal Injury ◽  
Anti Vegf ◽  
Bar Formation

Anti-VEGF-Therapie aus kardiologischer Sicht

2010 ◽  
Vol 227 (S 03) ◽  
Author(s):  
K Pels
Keyword(s):  
Anti Vegf

Diabetisches Makulaödem: Indikationen zur intravitrealen Anti-VEGF-Therapie und Laserkoagulation

2011 ◽  
Vol 228 (S 02) ◽  
Author(s):  
A Gabel-Pfisterer ◽  
F Heinemann ◽  
G Baader
Keyword(s):  
Diabetisches Makulaödem ◽  
Anti Vegf

Intravitreale Anti-VEGF-Therapie mit Bevacizumab bei diabetischem Makulaödem

2006 ◽  
Vol 223 (S 2) ◽  
Author(s):  
D Kook ◽  
A Wolf ◽  
AS Neubauer ◽  
SG Priglinger ◽  
A Hofer ◽  
...  
Keyword(s):  
Anti Vegf

Anti-VEGF bei reiner Pigmentepithelabhebung

2007 ◽  
Vol 224 (S 1) ◽  
Author(s):  
L Spetlikova ◽  
O Rudolph ◽  
R Effert
Keyword(s):  
Anti Vegf

Anti-VEGF-Therapie der serösen Pigmentepithelabhebung bei AMD

2007 ◽  
Vol 224 (S 4) ◽  
Author(s):  
A Lommatzsch
Keyword(s):  
Anti Vegf

Justification of optimal period for vitreoretinal intervention on the background of preoperative anti-VEGF therapy for proliferative diabetic retinopathy

2020 ◽  
pp. 13-15
Author(s):  
M.M. Bikbov ◽  
◽  
M.R. Kalanov ◽  
T.R. Gilmanshin ◽  
R.M. Zainullin ◽  
...  
Keyword(s):  
Diabetic Retinopathy ◽  
Proliferative Diabetic Retinopathy ◽  
Anti Vegf ◽  
Optimal Period
Sign in / Sign up

Export Citation Format

Share Document